$ME->Wakeup('2021-02-15 00:00:00');
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe "YOU" DIDNT KNOW ABOUT WARRANTS
RLF publishes audited financial statements on their website. They are audited by world industry leading tax and accounting firm, Mazars. They show all warrants and shares. There also was an announcement about the share subscription facility which you are blending in
In addition, the iHUB RLFTF page (Where you are reading this) has the number of shares and warrants listed as well. I know for a fact you called Dusseldorf but the status of the warrants evaded your RLFTF knowledge... Come on man, by now you (yes the real you) knows what's going on in the world and the potential Aviptadil has to help us all. Someday you will surely look back on these days and think how actions you took during this memorable point in time possibly could have affected its history. Would anyone want to live on knowing they caused a one day delay in approval OR would it be self gratifying to know they the might solely have helped get it approved a day early.
The time is coming soon, very soon. Engagement outside the US is already occurring as well significant steps within the US. TIK TOK
Best,
JB
Parlez-vous français ?
MUST READ DD INFO ON CSLI
CSLI is listed as a Shell Company on the OTC Markets
https://www.otcmarkets.com/stock/CSLI/profile
A Shell Company is a company, other than an asset-backed issuer, with no or nominal operations and either 1) no or nominal assets; 2) assets consisting of cash and cash equivalents; or 3) assets consisting of any amount of cash and cash equivalents and nominal other assets, as defined by Securities Act Rule 405 and Exchange Act Rule 12b-2. SEC reporting companies designate their shell status in their periodic filings.
They were "acquired" by MKH ventures
MKH ventures lists its "global" address as
MKH Ventures/Critical Solutions, Inc.
30 N Gould St Ste N
Sheridan, WY 82801
https://mkh-ventures.com/index.php/global-contact-us-page/
The address listed for CSLI is not a real office but is a "Virtual Office" address
A Wyoming virtual office is basically a package of services we’ve put together to make starting and maintaining your Wyoming company as affordable and easy as possible. As an example, when someone uses our Wyoming virtual office service, they will receive a business address; mail forwarding services; a Wyoming phone and fax number; access to our conference rooms and offices; and the ability to open a business bank account in Wyoming. Basically, with our Wyoming virtual office services, a business owner gains all the benefits of having an office, without paying to maintain an entire office.
https://www.wyomingcorporateoffice.com/
CSLI/MKH ventures lists their CEO as
Samuel Barraza
https://mkh-ventures.com/index.php/leadership/
Samuel Angel Barraza resides in TX and has several aliases:
-Bigtexsam
https://www.facebook.com/bigtexbbqfest
-SamKnight (Aspiring rapper)
Sam Barraza runs Big Tex Papas Stuffed Potatoes in Houston
https://www.facebook.com/bigtexpapas/
The CEO has indicated there is some audio issues with some hype cannabis video that is supposed to blow the roof off the stock price which one would think was odd considering he was able to fix the audio issues with his new "Galaxy" single at the beginning of this month.
This music video must have been prioritized rather than the investor video for CSLI
https://www.facebook.com/bigtexbbqfest/posts/1575939985940121
CSLI's own "unaudited" financials show no profit or assets --- only a 16,453,245 loss
This is the investment genius running the show for CSLI and leading it to "vast fortunes"
https://scontent-lga3-1.xx.fbcdn.net/v/t1.0-0/p526x296/123222423_1571690419698411_7189597430856318337_o.jpg
I think the truth about CSLI is apparent to anyone who looks. CSLI seems legit and vanely "weathered" huh?
Follow links and do your DD!
Best,
JB
Dump time again.
Its all good, honestly I wish ANY investor does well with their portfolio. So we can keep it at that unless you wish to continue on... It's a simple solution btw, GLTA
Cheers,
JB
RE: It means more institutional exposure.
Exactly, every fund that carries this index will own shares of RLF. It also further lends further credibility to the company as being significant to the Swiss economy. This is just yet another step up the ladder, more will come. RLF AG will be listed on the MCSI Swiss Small Cap on 11/30
https://app2.msci.com/eqb/gimi/smallcap/MSCI_Nov20_SCPublicList.pdf
I don't know where they will get the shares but know they are not getting any from me. I am an investor.
Best,
JB
RVVTF is a limbo party, how low can you go!
Sorry folks parks closed :( the RVVTF train is leaving the station, next stop nowhereville
Look at the VIRTUAL OFFICE for CLSI
MKH Ventures (CLSI) is
30 N Gould St Ste N,
Sheridan, WY 82801
A Wyoming virtual office is basically a package of services we’ve put together to make starting and maintaining your Wyoming company as affordable and easy as possible. As an example, when someone uses our Wyoming virtual office service, they will receive a business address; mail forwarding services; a Wyoming phone and fax number; access to our conference rooms and offices; and the ability to open a business bank account in Wyoming. Basically, with our Wyoming virtual office services, a business owner gains all the benefits of having an office, without paying to maintain an entire office.
https://www.wyomingcorporateoffice.com/
Half a billion CLSI shares out there and I wouldnt tust CLSI's CEO Sam Barraza with my money
https://mkh-ventures.com/wp-content/uploads/2020/10/Sam-Barraza-Profile-Pic.jpg
First, the most important elements to any drug are its safety and efficacy. The safety is undeniable given the amount of patients that have used this man made version of a peptide found in the lungs of every mammal for a variety of afflictions over the years. Its efficacy too seems undeniable as well, if you remember it has already been approved for years in the US and EU for ARDS. This is what makes COVID-19 deadly and what VIP is effective against. We have already seen preliminary results that appear to be world changing and have been promised more.
Most importantly, I have long known that when someone wants to tell you something but is restricted from doing so, they will drop breadcrumbs. Take for example the last drop, there was a linked in comment reassuring us results look great and are imminent. Look at yesterday; we learned about a vaccine and a therapeutic for mild to moderate. The company's twitter account puts out a statement. Look at the wording "we have always focused on patients with the highest unmet need" They have been focused on saving lives from the beginning and are telling us this is their lane and that lane is still wide open. They have been in constant communication with the FDA as well. We have not been denied anything and just the other day the DMC looked at the study results and these experts voted unanimously to keep the trial going. There is a scientific paper that says its akin to the first reports of penicillin treating pneumonia, that is a very bold statement. It would be like saying "this is the cure for cancer" in your paper and is not something someone would casually put in since it would jeopardize their reputation.
So I don't care about daily share price or the number of shares or a RS or whatever you see many bashers say... My only focus is does it work and is it safe. Until verifiable evidence shows me that is not the case, I will remain long with 6.4m shares of RLFTF currently. I am in good company as well, Credit Suisse opened a position recently and we are all hitching out wagon to GEMS. Smart money follows smart money. So its early and now I need my espresso since I will have many conversations today with so many who seem to focus on daily price swings. Nothing has changed, there has been a steady stream of positive news and all is well in my opinion.
Best,
JB
Hey K, There will be no uplist, there will be no EUA... Its over for RVVTF unfortunately, the writing has been on the wall. Watch the RVVTF drop tomorrow and wish you had gotten out today. Mark my words
This ship has sailed.... too bad. I will never see my 0.75 buyin price return, cutting my losses and moving on
Prolly to say trial failed....Its not looking very good for us rvvtf folks...Sad :(
He mentions the nasal spray at the 4:20 mark
https://www.msnbc.com/stephanie-ruhle/watch/dr-william-haseltine-says-virus-is-very-serious-despite-successful-pfizer-vaccine-trial-95595589898
Best,
JB
This is the biggest scam out there!!!
BEWARE, sell while you can!!!
This stock is the worst performing in my portfolio
Time to jump ship and sell
The 6 month trend DOWN DOWN DOWN
I will never get my money back... time to abandon ship!
I bought at 0.35, looks like I will never get back to even
This ship is sinking!
WOW!! It dropped 75% last week another 25% today!!! When is management going to tell us what’s so happening??? SOS coming as we fade away into the ocean of Covid....SAD :(
Looking like a dumpster fire for us investors today? What do you think is happening to our once proud stock? It keeps fading away :(
Looking like a dumpster fire for us investors today? What do you think is happening to our once proud stock? It keeps fading away :(
Nothing has changed, only news has been good. David Kessler will be announced as co chair of the Biden COVID task force. He has many many connections to NeuroRX team members. Our pending EUA is already in his radar. Don't get shook loose
Best,
JB
LOL :)
Great discussion going on now:
https://videocast.nih.gov/livew.asp?live=38975
This ship is sinking
SELL MORTIMER, SELL!!!
This ship is sinking
SELL MORTIMER, SELL!!!
Well that was an interesting exercise
"Adversity doesn't build your character. Adversity reveals your character."
-Unknown
Weak hands got shook loose of their RLFTF shares and the true colors of many were shown. If you step back and look at what transpired, it is obvious what happened with RLFTF and the motivation behind it. So how did you hold up against your first test? There will be more especially as the potential monetary gains from doing so increase.
I saw the turmoil as a great buying opportunity and added 1.8m more. After seeing the rebound today, I am ecstatic about. Every penny swing is now 64k rather than 46k :) Today's PR was just a tiny booster shot but more significant ones will come in due time.
The hard part about the past 2 days with RLFTF was the amount of people I had to "talk off a cliff" here and other places. In short the message to them was: Don't believe in me or any other person as your reason to invest in anything. Do your own DD and if you believe in the company and its product, THEN invest. Once you have done that, the daily price per share is irrelevant as you will know your own personal endpoint is when you will sell.
All is well and the only news has been very positive. Stay long.
Best,
JB
Elections of the Board of Directors, Chairman of the Board of Directors, Nomination and Compensation Committee, Independent Proxy Holder and Auditors
The General Meeting decided to re-elect for the period of one year between the OGM 2020 until the OGM 2021, three previous members of the Board of Directors, namely Dr. Raghuram Selvaraju, Mr. Peter De Svastich, and Mr. Thomaz Burckhardt. In addition, the General Meeting elected a new member of the Board of Directors, Prof. Jonathan Javitt, Founder and Chief Executive Officer of NeuroRx Pharma. The General Meeting confirmed Dr. Selvaraju as Chairman of the Board of Directors.
“It is an honour and privilege to have Professor Jonathan Javitt join the Board of Directors of Relief Therapeutics Holding. His arrival will enhance the relationship between NeuroRx and Relief Therapeutics Holding and set the stage for successful clinical development.” said Dr. Raghuram Selvaraju, Chairman of the Board of Directors.
https://www.relieftherapeutics.com/newsblog/30-relief-therapeutics-holding-sa-six-rlf-shareholders-approve-all-resolutions-at-its-ordinary-general-meeting-2020-prof-jonathan-javitt-elected-vice-chairman-of-the-board-of-directors
Now gimme my damn prize...
JB
He is how we are going to get it done in Israel
Chairman of the Board of Directors
Kitov Pharmaceuticals
Jul 2013 - Present7 yrs 5 mos
Jerusalem, Israel
https://www.linkedin.com/in/paul-waymack-m-d-sc-d-bbb40b8
Best,
JB
Only more positive news has occurred
MMs will shake away weak trader hands, this is why I have stressed to ignore daily noise. The share price fallout spooked some but not real investors. GEM isnt selling their stake -- I too am not. I am putting another 1m on the line today as I see it as a buying opportunity. They should announced the addition of a regulatory consultant -- if there was a problem, they wouldn't have bothered.
RELIEF APPOINTS J. PAUL WAYMACK, M.D., SC.D. AS CONSULTANT TO STRENGTHEN MANAGEMENT TEAM
04 November 2020
Geneva, Switzerland, November 04, 2020 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today announced the appointment of J. Paul Waymack, M.D., Sc.D. as development and regulatory consultant. Dr. Waymack will strengthen the management team in all activities pertaining to the late stage development of RLF-100™, including regulatory activities. He will also be responsible for establishing Relief's new Clinical Advisory Board and recruiting experts to join this body, in close collaboration with Relief's Chief Medical Officer, Gilles Della Corte, M.D.
Dr. Waymack has an extensive track record in the pharmaceutical drug development arena and currently serves as President of Waymack Consulting, which provides expert services to healthcare companies. He was the founder of Kitov Pharmaceuticals and served as its Chairman of the Board of Directors as well as its Chief Medical Officer from the company's founding until his retirement in 2019. During his tenure, Kitov was granted U.S. FDA approval for its NDA for its first drug, Consensi™ (amlodipine plus celecoxib), for the simultaneous treatment of osteoarthritic pain and hypertension. Prior to founding Kitov, Dr. Waymack was a U.S. FDA medical officer, an associate professor of surgery and director of the surgical intensive care unit at the New Jersey School of Medicine and Dentistry. He was also formerly chief of surgical studies at the U.S. Army’s Institute for Surgical Research. Dr. Waymack has been granted multiple patents and has authored or co-authored over 100 publications. He currently sits on multiple boards of directors and advisory boards for companies within the pharmaceutical industry. He received his medical degree from the Virginia Commonwealth University School of Medicine.
Raghuram (Ram) Selvaraju, Chairman of the Board of Relief, said: “I am thrilled to have Paul join us on our journey to see RLF-100™ through clinical development and reach those COVID-19 patients who so desperately need new therapeutic options. His extensive experience in drug development and intimate understanding of the workings of the FDA will be invaluable to Relief."
“Relief's team is in the midst of an exciting time as they work diligently to advance RLF-100™ through late stage development at a pace unprecedented in the field. I am delighted to join and support them in the final stages of development for this promising drug candidate and hopefully through regulatory approval,” commented J. Paul Waymack, M.D., Sc.D., Consultant for Relief.
ABOUT RELIEF
Relief focuses primarily on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical testing and use in human patients or a strong scientific rationale. Currently, Relief is concentrating its efforts on developing new treatments for respiratory disease indications. Its lead drug candidate RLF-100™ (aviptadil), synthetic vasoactive intestinal peptide (VIP), is being investigated, in cooperation with NeuroRx Inc., in two placebo-controlled U.S. Phase 2b/3 clinical trials in respiratory deficiency due to COVID-19. RLF-100™ is believed to be the first COVID-19 therapeutic to demonstrate the ability to block replication of the SARS-CoV-2 virus in human lung cells and monocytes, while also preventing synthesis of cytokines in the lung. Since July 2020, severe COVID-19 patients have been treated with RLF-100™ under U.S. FDA Emergency Use Investigational New Drug (IND) authorization and Expanded Access Protocol authorization for the treatment of respiratory failure in COVID-19. Relief also holds a patent issued in the United States and various other countries covering potential formulations of RLF-100™.
RELIEF THERAPEUTICS Holding AG is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbol RLFTF.
https://relieftherapeutics.com/newsblog/119-relief-appoints-j-paul-waymack-m-d-sc-d-as-consultant-to-strengthen-management-team
There has been ZERO negative news with RLFTF... zero. So what would you think is going on besides manipulation and weak hands letting go due to a lack of patience or ignorance about RLF-100's efficacy. I have a high level of confidence there is "something" this new consultant will have to advise on regulating or it wouldn't have proceeded and been announced. All is well with RLFTF from my perspective again I now decided I will be adding a significant amount more and holding since I can reinforce my position and grab even more shares at a great entry price. You do you, I am following along with GEM.
Best,
JB
Nothing has changed. You read linked in comments and saw BARDA attendee list right?
Best,
JB
Big Brass Bulls
Can be a term used to relate to some shareholders stance on their RLF AG holdings. Many have bought and held their RLFTF shares a while ago but there is one group of RLF AG shareholders that doesn't seem to get mentioned here often. That group would be Rem. (who has an extensive background as an analyst specializing in the medical field) and GEM which is self described 3.4B investment group.
"Rem" the analyst saw the potential of what Mondo Pharma had held and what RLF now had the IP rights to far earlier than any of us. He realized this drug which already recieved US and EU approval for serious respiratory illnesses had potential. Then some bigger players came in, GEM. With a 600m commitment that would be 1/6 of their holdings they were putting on the line for a significant majority stake in RLF AG. These earliest RLFTF investors know about big brass bulls surely.
You need to understand what GEM is and what they do as it is a defining element that controls how this ends. They acquire and sell, period. Using the black-scholes method it was pointed out to me the 50.3 significance of the value of GEM's holdings and warrants. They also put out a very public "Company for sale" sign on the 8/26 that showed off the clean balance sheet and that GEM is in control.
They have no desire to run a pharma company nor will they dribble their RLFTF shares to the public slowly. They know what that have and that approval is basically undeniable. Once they see that approval and some really solid potential for even more would be my hypothesis as when that will occur. They may pull the trigger and sell but the to whom, the when and the for how much will allude us all for some time. There are even starting to be clues about that. When, to who, for how much...
Now, I understand many here are very enthusiastic about anecdotal stories, events etc that they might think they can possibly even change the RLF-100 Approval & Eventual company sale but can tell you they will not. Following day by day 1 patient, trying to generate RLFTF PR via political reachout and even petitions will not change what is coming. Think about is this way: You have hitched your wagon to GEM and the NueroRX dream team. Just hold tight and enjoy the ride.
Enjoy life to the fullest since we each only have a finite amount of time here, your RLFTF investment will take care of its self and be very profitable. For some, their RLFTF postions might be their first taste of new found wealth. I would stress that when that occurs to remain humble in every aspect such as your assets and investment knowledge. After this RLFTF story ends, remember this will not always be the case with every play and the odds are that you are not the absolute "best" at anything because of what is going to occur with RLFTF.
When I engage with various online communities every crowd is different as is the case with RLFTF shareholders. The groups talking about biothermal powered devices, solar desalination, tidal power generation etc are all distinct much like the RLFTF shareholders I see and sometimes engage with. One thing I seem to have noticed about RLFTF shareholders is they seem to like a good story, so here goes my RLFTF parable:
There was a pair of big brass bulls on a hill. An old RLFTF bull and a young RLFTF bull. The young bull noticed the old bull staring at a bunch of new RLFTF generated money down in the meadow. The young bull got very excited jumping up and down and said to the old RLFTF bull "Lets RUN down there and get us some of that new RLFTF money!!!" The old bull, continued to chew his hay for a bit and then said to the young RLFTF bull "How about we WALK down there and get ALL of that RLFTF money"
Cheers,
JB
I do not believe Kaplan Meier takes into account any case weighting. Risk of mortality and severity of illness scores using something good like 3m's APR DRGs (Which I'm impartial to since I helped develop) can be used to obtain better risk adjusted rates and risk adjusted confidence intervals as shown. Just my 2 cents. PS Vote
Best,
JB
RE: It is also important to note the important RLF100
It is also a extremely powerful bronchodilator and vasodilator. Then again, new information regarding VIP in the body comes out all the time. Here are some recent articles (credit to Insightful Penguin):
https://www.biorxiv.org/content/10.1101/2020.10.26.355123v1.full.pdf
https://www.sciencedirect.com/science/article/abs/pii/S0143417920300950?via%3Dihub
http://code3systems.com/category/nhe/?fbclid=IwAR0p3Z4A5atigukYFN28hEMCyvzNEBAlTnHtB18XHDDBeqRI42Wn4CpWs38
https://www.nature.com/articles/s41392-020-00345-x?fbclid=IwAR0p7Z3cplFh1VRm9oYfwt-l4o6g0n-PLR3hOlhFtThoKKw8kKNY_Ca4DGc
https://link.springer.com/article/10.1007/s10517-020-04979-3
A miracle from God, akin to discovering penicillin... Honestly, I don't know the full extent of what it can do. I do know I am happy to own 0.2% of the entire company in my portfolio though.
Cheers,
JB
SELL MORTIMER, SELL!!!!
This ship is sinking fast, get out while you can. Management is a complete disaster
RE: The 165 is the 144 plus
Increasing population size reduces the size of the 95% confidence interval, further reinforcing the statistical significance of the results. All is well, stay long
Best,
JB
Big News from our partners over at $RLFTF today. Good for them!
RE: It is indeed a sad situation...
"A response of this magnitude has previously not been seen with an antiviral agent and is akin to the first reports of penicillin in treating pneumococcal pneumonia."
Not only will we all make a significant amount of gains, we also all will know more about this treatment than most. This is unlike any other investment I have... I feel like I am involved in saving the human race and have 1m on the line that has the potential to be a 50x bagger. Nothing any of us do say or think will change the process. Patience is all that is required, stay long -- smart money already has been doing that for a while.
Best,
JB
RVVTF is one of the biggest scams out there and can not be compared to a peptide that is found in the lungs of every mammal on earth such as RLFTF(VIP). RLFTF has a market cap over a billion already. You keep thinking that the share count mattesr -- No a drugs efficacy is what matters son! Now stay here and eat RVVTF 'shrooms with your friends
JB